Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 8 910 JPY -0.47% Market Closed
Market Cap: 4.8T JPY
Have any thoughts about
Otsuka Holdings Co Ltd?
Write Note

Relative Value

The Relative Value of one Otsuka Holdings Co Ltd stock under the Base Case scenario is 7 419.82 JPY. Compared to the current market price of 8 910 JPY, Otsuka Holdings Co Ltd is Overvalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7 419.82 JPY
Overvaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
53
Median 3Y
1.5
Median 5Y
1.6
Industry
2.5
Forward
2.1
vs History
4
vs Industry
16
Median 3Y
22.3
Median 5Y
17.1
Industry
21.9
Forward
20.5
vs History
20
vs Industry
25
Median 3Y
11.6
Median 5Y
10.9
Industry
16.5
vs History
92
vs Industry
13
Median 3Y
35.3
Median 5Y
28.3
Industry
23.6
vs History
1
vs Industry
46
Median 3Y
1.2
Median 5Y
1.2
Industry
2.1
vs History
1
vs Industry
56
Median 3Y
1.3
Median 5Y
1.4
Industry
2.6
Forward
1.9
vs History
3
vs Industry
65
Median 3Y
2
Median 5Y
2
Industry
5.2
vs History
20
vs Industry
36
Median 3Y
7.8
Median 5Y
7.6
Industry
13.3
Forward
9.3
vs History
46
vs Industry
34
Median 3Y
11
Median 5Y
10.6
Industry
16.6
Forward
16.9
vs History
19
vs Industry
27
Median 3Y
10.3
Median 5Y
9.7
Industry
15.6
vs History
41
vs Industry
14
Median 3Y
19.3
Median 5Y
17.9
Industry
19.1
vs History
1
vs Industry
49
Median 3Y
0.9
Median 5Y
1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Otsuka Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Otsuka Holdings Co Ltd
TSE:4578
4.8T JPY 2.1 31.8 8.6 10.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Otsuka Holdings Co Ltd
TSE:4578
Average P/E: 32.3
31.8
117%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top